Journal of Biopharmaceutical Statistics

Title Publication Date Language Citations
Agreement Between Methods of Measurement with Multiple Observations Per Individual2007/07/02English1,291
MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets2009/02/12English245
Weighted Gene Coexpression Network Analysis: State of the Art2010/03/19English241
An Overview on Assessing Agreement with Continuous Measurements2007/07/02English226
Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group2006/07/01English189
On the Use of Zero-Inflated and Hurdle Models for Modeling Vaccine Adverse Event Count Data2006/08/01English162
Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation2013/10/18English158
Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials2007/11/08English133
Practical modifications of the continual reassessment method for phase i cancer clinical trials1994/01/01English133
Structure-activity maps for visualizing the graph variables arising in drug design1993/01/01English122
An Overview of Practical Approaches for Handling Missing Data in Clinical Trials2009/10/21English105
A useful testing strategy in phase iii trials: combined test of superiority and test of equivalence1995/01/01English104
Common noncompartmental pharmacokinetic variables: are they normally or log-normally distributed?1997/01/01English99
Interaction Index and Different Methods for Determining Drug Interaction in Combination Therapy2007/05/01English99
The Fallback Procedure for Evaluating a Single Family of Hypotheses2005/11/01English95
Stability Investigations of Multivariable Regression Models Derived from Low- and High-Dimensional Data2011/10/24English92
A Unified Approach for Assessing Agreement for Continuous and Categorical Data2007/07/02English88
A Bayesian Approach to the ICH Q8 Definition of Design Space2008/09/05English86
A comparison of the random-effects pattern mixture model with last-observation-carried-forward(locf) analysis in longitudinal clinical trials with dropouts1998/01/01English81
Sample Size Re-Estimation for Adaptive Sequential Design in Clinical Trials2008/11/07English80
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review2015/09/17English79
Statistical Issues Including Design and Sample Size Calculation in Thorough QT/QTc Studies2008/05/08English78
Bayesian decision procedures based on logistic regression models for dose-finding studies1998/01/01English78
A Bayesian Approach to Subgroup Identification2014/01/02English75
Clinical Trial Designs for Predictive Biomarker Validation: One Size Does Not Fit All2009/04/21English72
Dose response studies II. analysis and interpretation1995/01/01English68
Sample Sizes Required to Detect Two-Way and Three-Way Interactions Involving Slope Differences in Mixed-Effects Linear Models2010/05/19English68
Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies2019/09/03English67
Last Observation Carried Forward: A Crystal Ball?2009/08/07English65
Design and Analysis of Dose-Finding Studies Combining Multiple Comparisons and Modeling Procedures2006/10/01English61